Ocram is installing Air Handling Units on the Serum Institut of India facilities. The Indian giant has invested tenths of thousands in resources to produce COVID-19 Vaccines.
Roughly 6 weeks ago 16 containers left OCRAM’s facilities heaving India as the final destination. These are the first part of a bigger order and in the following months, many more containers will leave for Serum Institut of India to treat the air of the recently built facilities aimed at welcoming the development of the much needed COVID-19 Vaccine.
OCRAM happily embraces the responsibility to secure air quality in a complex where crucial developments for all mankind are taking place.
THE SERUM INSTITUTE OF INDIA
The Serum Institut of India Pvt. Ltd is the biggest vaccine producer in terms of the number of doses produced and sold globally – over 1.5 billion doses. The Institut has been working with multiple entities worldwide in vaccine production. Over the past 5 years, it has developed and conducted multiple global clinical trials leading to the approval of its own pneumococcal vaccine to immunise children against Streptococcal pneumonia. According to the World Health Organization, pneumonia is a major contributor to childhood mortality around the world. In India alone, 70 to 80 million doses of the vaccine are needed.
ON THE RUN WITH OXFORD FOR ASTRA-ZENECA COVID-19 VACCINE
The Serum Institut of India is partnering with AstraZeneca pharmaceuticals and supporting Oxford University in the development of a vaccine against COVID-19. The first results were published in “The Lancet” science publication and described the vaccine as safe and bearing a good immune response in almost every person who took part in the trials. Astra-Zeneca produced neutralising antibodies to SARS-CoV-2 and with few side effects. At this moment, another phase of clinical trials will follow, sampling a group with 4000 people, in countries where more cases have been reported in recent weeks, such as Brazil and South Africa.
Adar Poonawalla, CEO of Serum Institut, told The Indian Express this week that they plan to make millions of vaccines for COVID-19 over the next 3 months. But he warns that “the world will have to wait a long time before everyone can get vaccinated. There is a large number of doses to produce and this includes the challenge of delivering these doses to all parts of the world.
According to the World Health Organization, 149 vaccines are being developed in the world. The first one licensed may not necessarily be the best. Among multiple scientific approaches, we will have to wait and confirm which one, or which one will be given to the world.
The Serum Institut also produces VPM BCG which is currently in trials with over 1000 patients. The next two months will demonstrate how effective it is in reducing the severity of COVID-19.
OCRAM is pleased to contribute its technology to ensure the better air quality in facilities that may eventually give the world the solution we all longed for.